# Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

> **NCT01610245** · PHASE3 · COMPLETED · sponsor: **Romark Laboratories L.C.** · enrollment: 1941 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Nitazoxanide
- **DRUG:** Oseltamivir
- **DRUG:** Placebo Oral Tablet
- **DRUG:** Placebo Oral Capsule

## Key facts

- **NCT ID:** NCT01610245
- **Lead sponsor:** Romark Laboratories L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2015-03
- **Final completion:** 2015-04-16
- **Target enrollment:** 1941 (ACTUAL)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01610245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01610245, "Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT01610245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*